Workflow
港交所最新宣布！又一对冲工具来了，涉及最火赛道
券商中国·2025-10-14 12:22

Core Viewpoint - Hong Kong Exchanges and Clearing Limited (HKEX) plans to launch the Hang Seng Biotechnology Index Futures on November 28, 2025, providing effective risk management tools for the rapidly growing biotechnology sector [2][3][4]. Group 1: Product Details - The new futures contract will have the code HBI, with a contract multiplier of HKD 50 per index point, and will be available for trading in the current month, the next three months, and the following three quarterly months [3]. - The first six months of trading will be exempt from the Securities and Futures Commission transaction fees, with the margin rate to be announced later [3][4]. Group 2: Market Context - The biotechnology sector is currently one of the hottest and fastest-growing industries in the Hong Kong capital market, driven by technological innovation and global healthcare demand [4]. - The Hang Seng Biotechnology Index has recorded a 63.61% increase over the past year, significantly outperforming the Hang Seng Index, which rose by 20.62% [4]. - Year-to-date, the Hang Seng Biotechnology Index has surged by 90.33%, surpassing the Hang Seng Technology Index's increase of 37.54% [4]. Group 3: Major Constituents - The index tracks the 30 largest biotechnology, pharmaceutical, and medical device companies listed on the Hong Kong Stock Exchange, with major constituents including WuXi Biologics, BeiGene, and Innovent Biologics [4][5]. - The top ten weighted stocks in the index include: - WuXi Biologics (10.83% weight, market cap HKD 120.825 billion) - BeiGene (10.21% weight) - Innovent Biologics (9.18% weight, market cap HKD 139.0 billion) - And others, contributing to a diverse representation of the sector [5]. Group 4: Industry Growth - Since the listing reforms in 2018, the biotechnology and healthcare sectors have become the fastest-growing industries in Hong Kong, with over 260 companies listed and a total market capitalization exceeding HKD 4.8 trillion, quadrupling from approximately HKD 1.2 trillion at the end of 2018 [6].